VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Conditions:   Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia Interventions:   Drug: Tamsulosin 0.2mg + Solifenacin 5mg;   Drug: Tamsulosin 0.2mg + Placebo(Solifenacin) Sponsor:   Jeil Pharmaceutical Co., Ltd. Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2016 Category: Research Source Type: clinical trials

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
Condition:   Benign Prostate HyperplasiaInterventions:   Drug: Tamsulosin;   Drug: Solifenacin;   Drug: Solifenacin placeboSponsor:   IlDong Pharmaceutical Co LtdRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2016 Category: Research Source Type: clinical trials

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
Condition:   Benign Prostate HyperplasiaInterventions:   Drug: Tamsulosin;   Drug: Solifenacin;   Drug: Solifenacin placeboSponsor:   IlDong Pharmaceutical Co LtdRecruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2016 Category: Research Source Type: clinical trials